City of Hope (IMAGE)
Caption
Researchers at City of Hope were awarded $32.3 million from the California Institute for Regenerative Medicine (CIRM) to support three novel Phase 1 clinical trials evaluating innovative cell and gene therapy treatments for patients with HIV, acute myeloid leukemia and severe aplastic anemia.
Credit
City of Hope
Usage Restrictions
Please use photo credit
License
Original content